Skip to content
OpenCapital
Get started

Edgewise Therapeutics, Inc. EWTX Enterprise value

Enterprise value at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$158.92B-2.6%
Cytokinetics logo
CytokineticsCYTK
$8.41B+70.7%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$5.2B+77.3%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$2.27B-4.1%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$2.41B+228%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$3.81B-14.5%

Other financials

Income statement

See full
Operating income-$54.1M-17.7%
Net income-$49.0M-20.1%
EPS (diluted)-$0.46-7.0%

Balance sheet

See full
Cash & equivalents$33.2M-33.5%
Total debt$3.8M-16.8%
Total equity$493.2M+14.8%
Total assets$518.5M+14.1%

Cash flow

See full
Operating cash flow-$42.5M-12.4%
CapEx$260.0K+491%
Free cash flow-$42.8M-12.9%

Valuation

See full
Market cap$3.96B+61.3%

Returns & leverage

See full
Return on equity-38.1%+13.4pp
Debt / equity0×0.0×
Current ratio22.6×+1.6×

Where this comes from

Calculated from Edgewise Therapeutics, Inc.’s reported figures.

$3.4Bmarket cap+$3.8Mtotal debt−$33.2Mcash and equivalents=$3.35B

The official record: Edgewise Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Edgewise Therapeutics, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Edgewise Therapeutics, Inc.'s enterprise value?
Edgewise Therapeutics, Inc. (EWTX) reported enterprise value of $3.35B in Q1 2026.
How has Edgewise Therapeutics, Inc.'s enterprise value changed year-over-year?
Edgewise Therapeutics, Inc.'s enterprise value increased by 63.5% year-over-year, from $2.05B to $3.35B.
What is the long-term trend for Edgewise Therapeutics, Inc.'s enterprise value?
Over 3 years (2022 to 2025), Edgewise Therapeutics, Inc.'s enterprise value has grown at a 67.4% compound annual growth rate (CAGR), from $547.71M to $2.57B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.